Your session is about to expire
← Back to Search
Using Visual Feedback to Influence Rapid Response in the Treatment of Eating Disorders
N/A
Waitlist Available
Led By Michele M Laliberte, Ph.D.
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 6, 10, and up to 25 weeks (end of group treatment)
Awards & highlights
No Placebo-Only Group
Summary
This study has two aims: 1) to test the validity of an eating disorder symptom checklist against an established clinical interview; and 2) to examine whether providing eating disorder patients with visual graphs of their symptom frequency in the early sessions of active treatment will lead to higher numbers of patients achieving a "rapid response" (65% reduction in symptoms in the first 4 weeks of treatment). Groups where patients receive visual graphs of symptom frequency will be compared with groups where patients do not receive visual graphs of symptom frequency on rates of rapid response to cognitive behavior treatment for eating disorders.
Eligible Conditions
- Bulimia Nervosa
- Bulimia
- Binge Eating Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at week 6, 10, and up to 25 weeks (end of group treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 6, 10, and up to 25 weeks (end of group treatment)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in eating disorder symptoms from baseline
Secondary study objectives
Eating Disorders
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Visual feedback of symptom frequencyExperimental Treatment1 Intervention
Participants in this arm receive visual feedback of their symptom frequency over the first 4 weeks of active treatment, based on information they provide on a symptom checklist.
Group II: No visual feedback of symptom frequencyActive Control1 Intervention
Participants in this arm complete the symptom checklist as is typically done during treatment, but receive no visual feedback of their self-reported symptom frequency over the first 4 weeks of active treatment.
Find a Location
Who is running the clinical trial?
St. Joseph's Healthcare HamiltonLead Sponsor
202 Previous Clinical Trials
26,845 Total Patients Enrolled
1 Trials studying Bulimia Nervosa
160 Patients Enrolled for Bulimia Nervosa
Michele M Laliberte, Ph.D.Principal InvestigatorSt. Joseph's Healthcare Hamilton